sBMYear=2024 and sBMMonth=4
sCurrentPeriodOrder=220 for period=April,2024
FertAid/IVFCPD-List of Webinars.

Open Subscriptions and Cart Status

IVFCPD Webinars and Podcasts
 
  Chapters
Clinical Female
Clinical Male
ART Treatment
Patient Care
Embryology
Andrology
Nursing and Counselling
Quality/Clinic Management
Training/education
Products/Groups/News
 
Webinars
Podcasts

Filter
IVF Worldwide
Cooper Surgical
FUJIFILM Irvine Scientific
Irvine Scientific
SART FERTILITY EXPERTS
The International IVF Initiative - i3
VITROLIFE

  SOURCES
II3
Cooper Surgical
CS Podcasts
FujiFilm Irvine
SART Podcasts
Vitrolife
IVF Worldwide
 

 
 
 
Webinar List  
  ID Name            
186 Adrenal Hyperandrogenism - ASPIRE   1
185 EXTREME IVF- I3 SESSION 127   0
184 CELLF CONTROL - I3 SESSION 126   0
183 FERTILIZATION- WHAT MATTERS? #SESSION 125   20
182 ART IN AFRICA . # SESSION 124   18
181 WHEN DISASTER STRIKES. #SESSION 123   19
180 NAVIGATING INTERNATIONAL SURROGACY #Session 122   18
179 TRACE ELEMENTS. #Session 121   10
178 CROSSOVER # Session 120   19
177 RBMO LIVE: Episode V   35
176 RBMO Live: Episode IV   28
175 RBMO LIVE: Episode III   30
174 KPIs - keep plodding indefinitely or keep performing impeccably?!   35
173 RBMO LIVE: EPISODE II   32
172 RBMO LIVE #1   30
171 When to Stop Storage: Improving Conversations About Unused Embryos   43
170 Your Guide to Genetics and Genomics in the Fertility Clinic   47
169 Counselling and Assisted Reproduction: When, Why and by Whom Should It Be Offered?   51
168 Session 69: The embryo in culture: Imprinting, oxidative stress and epigentic changes.   79
167 Session 71: Generations   51
166 Paternal aging and spontaneous mutations in the embryo: potential causes and consequences   57
165 The busines of operating multiple ART laboratories.   46
164 A Review: When to Transfer and What To Transfer?   45
163 New strategies to optimize ovarian stimulation for IVF/ICSI: a window to the future   49
162 How an Unlikely Technology became Routine Fertility Treatment: Remembering the First Pioneers of IVF   52
161 The clinical impact of next generation sequencing NGS in reproductive medicine   75
160 The potential of in vitro maturation of primordial (non-growing) follicles   57
159 Why and how to supplement androgens in infertile women?   96
158 Are we ready for clinical applications of the nuclear transfer technique?   62
157 A discussion with Prof. Klaus Dugi, EVP and Chief Medical Officer at Ferring Pharmaceuticals   53
156 Fertility preservation and endometriosis   52
155 Ovarian Endometrioma related to infertility: Surgery of IVF first?   51
154 AMH: the importance of its clinical use   76
153 Ovary transplant and IVM to preserve fertility in young cancer patients   50
152 Progesterone – Mode of Action   66
151 How to define successful IVF   77
150 The clinical aspects of the different formulation of progesterone   99
149 Progesterone supplementation: Effects & optimization of duration on live IVF/ICSI birth rates   83
148 Fertility preservation in women: Where are we in 2020?   53
147 Implantation: the rold of the embryo and the enometrium   55
146 Optimizing Endometrial Preparation for Frozen Embryo Transfer   62
145 A fertility center in NYC going through COVID-19, economic depression and riots   73
144 The Danish Fertility Preservation Programme   53
143 Progestin Primed Ovarian Stimulation   49
142 Fresh and Frozen: When and Why?   52
141 Sperm selection with hyaluronic acid improved live birth outcomes   48
140 How to streamline your workflow and secure good results with oocyte vitrification. [Vitrolife]   49
139 Retrospective clinical dataset of 7000 warmed blastocysts with an optimised, closed vitrification system [Vitrolife]   49
138 Closed and open carrier devices for vitrification [Vitrolife]   49
137 Antioxidants in Human IVF - an innovation in culture media. [Vitrolife]   48
136 Oil in IVF CUlture - a ligth or heavy oil decision. [Vitrolife]   55
135 Latest technologies in embryo selection [Vitrolife]   52
134 iDA Score - Changing the paradigm of embryo evaluation.   41
133 Past, Present and Future of Time-lapse in clinical IVF   73
132 Breaking new ground in embryo evalution   75
131 If quality is your outcome, then governance must be your business [NATA]   58
130 Why you should “risk” everything [NATA]   49
129 Is your laboratory future fit? What can be done today to be ready for tomorrow? [NATA]   48
128 Accreditation in the crosshairs [NATA]   48
127 FAMOUS   49
126 A Review: When to Transfer and What To Transfer?   52
125 This Changes Everything: A Fundamental Shift in Embryo Culture   98
124 Life Whisperer Viability Webinar Series webinar 3   48
123 Life Whisperer Viability Webinar Series webinar 2   51
122 Life Whisperer Viability Webinar Series webianr 1.   52
121 Basic Conditions for the Transport of Vitrified Specimens   54
120 Behind the Scenes of Media Development   49
119 Trending Topics Within the IVF Laboratory   57
118 Everything You Wanted to Know About Vitrification Media but Didn’t Know Who to Ask   50
117 3 Tips to Simplify 3 Procedures in the IVF Lab   103
116 Closed System Vitrification, What have we learned so far?   51
115 Vitrification Media Composition - The Important Roles of the Components   50
114 MEGA - Technical Aspects of How & Why It Works   53
113 Sperm Cryopreservation Update: Cryodamage, Markers, and Factors Affecting Sperm Freezing   39
112 Critical Parameters of IVF   80
111 The curious case of lactate, a blastocyst and an endometrium   61
110 SPERM-DRIVEN AND SPERM-TEMPLATED MICROROBOTS   42
109 AI facial matching for gamet donors and recipients.   62
108 The emotional experience of infertility and how we can support our patients.   52
107 Mechanistic analysis of sperm selection with hyaluronic acid and treatment outcomes   64
106 Using electronic witnessing to minimize IVF errors   51
105 Quality control in the clouds.   53
104 Paternal Aging and spontaneous mutations in the embryo: potential causes and consequencesQUENCES   58
103 THE ART OF CONSERVING ENDANGERED SPECIES   83
102 Live from PGDIS with our genomics experts   56
101 ICSI - Past, Present & Future   55
100 BRILLIANT MINDS: NEW APPROACHES IN ART AND FERTILITY TREATMENT   56
99 The-importance-of-quality-control-in-the-human-ivf-laboratory   49
98 ZYMOT FERTILITY SYMPOSIA   55
97 ERA Online Panel discussion - How to prepare a healthy endometrium?   59
96 pH Deep Dive   54
95 INTRODUCTION TO QUALITY CONTROL - PART II   48
94 INTRODUCTION TO QUALITY CONTROL - PART 1   49
93 I3 GOES MAVERICK -The Maverick Reproductive Biologist-Oil overlayis in IVF   51
92 Artificial Intelligence in ART   89
91 KEEP PLODDING INDEFINITELY OR KEEP PERFORMING IMPECCABLY?!   101
90 Driving efficiencies in IVF upwards.   97
89 The human Y chromosome and the future of men.   53
88 MINDING THE GAPS: REFLECTING ON THE STATE OF EMBRYOLOGISTS   51
87 RECALCULATION: HOW MANY EMBRYOLOGISTS DO I NEED?   46
86 Oocyte pick up: How to prepare patients   54
85 Oocyte pick-up: Laboratory standards and recommendations   51
84 Oocyte pick up: Advice on clinical team communication   46
83 How RI Witness can help prevent mismatches   61
82 Electronic Witnessing: Lessons over ten years   58
81 Fertility preservation for cancer patients: In Vitro Maturation (IVM) and its role in oncofertility   51
80 Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes   53
79 PATERNAL AGING AND SPONTANEOUS MUTATIONS IN THE EMBRYO: POTENTIAL CAUSES AND CONSEQUENCES   55
78 PRECISION MEDICINE IN REPRODUCTION: TIME FOR PREDICTION AND PREVENTION   49
77 Factors influencing success in donor IUI for lesbian and single women - the clinic   84
76 Factors influencing success in donor IUI for lesbian and single women - the laboratory   63
75 The Chamber of Secrets- Endometrial Preparation and Embryo Transfer   51
74 Implantation: the rold of the embryo and the endometrium   61
73 Embryo selection with artificial intelligence: how to evaluate and compare methods   78
72 Artificial shrinkage for blastocyst vitrification   50
71 Why does osmolality matter? Observations, drift, explanations, and counter   81
70 Laboratory Planning, Maintenance and Engineering Now and in the Future   53
69 New England Fertility Society VIRTUAL MEETING SERIES ~ Part I   82
68 How to Keep Gametes and Embryos from Environmental Harm   41
67 Assisted Reproductive Technology in Endangered Species Conservation   52
66 Preimplantation Genetic Testing, Recent Advances in Reproductive Medicine   56
65 What Genomics Dreams Might Come   41
64 Secrets of Implantation   54
63 The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART   54
62 Evidence based best practice in ooctye pick-up: a clinical perspective   50
61 MIGHTY MOLECULES IN REPRODUCTION   75
60 Managing Quality in the ART Laboratory   75
59 PGT-A in the Lab - Improving Outcomes and Techniques   55
58 The future of embryology. Technological advant-gardes in embryo selection   50
57 Why and how to supplement androgens in infertile women?   84
56 Principles of Cryopreservation and Optimization of Vitrification   53
55 CRYOGOVERNANCE IV   53
54 Demystifying mosaicism: The future   72
53 Demystifying mosaicism: Innovation and technology   65
52 Demystifying mosaicism: Where did it all begin?   59
51 Marginal Gains 3: Optimising culture conditions   52
50 Marginal gains 2: Dish set-up   53
49 Marginal gains: An introduction to the principles of marginal gains and its application in the IVF lab   55
48 Fertility preservation for cancer patients: optimizing oocyte recovery for IVM   52
47 WHO laboratory manual for the examination and processing of human semen   55
46 Evidence based best practice in embryo transfer   55
45 Optimizing your embryo culture system   52
44 More or Less   50
43 Cryogovernance II   55
42 CRYOGOVERNANCE III: THIN ICE   55
41 What to really expect from oocyte vitrifcation   51
40 IVFCPDVIDEO- Viotti   63
39 IVF in the Time of COVID-19   57
38 3 Tips to Simplify 3 Procedures in the IVF Lab   105
37 Critical Parameters of IVF   53
36 Cryogovernance   45
35 Basic Conditions for the Transport of Vitrified Specimens   81
34 SART Fertility Experts - Your Infertility Nurse: Partner in Your Care   51
33 SART Fertility Experts - Behind the Scenes in the IVF Lab   99
32 Piezo_ICSI Hiraoka   49
31 MOVING SPERM FORWARD   53
30 Laboratory Controlled Factors Impacting IVF Culture Media Performance   54
29 Evaluation of IVF laboratory outcomes with key performance indicators   73
28 KPI CARE   53
27 LEGACY PART 1: RECRUITMENT, TRAINING, TALENT MANAGEMENT AND SUCCESSION PLANNING   52
26 LEGACY PART2 : RECRUITMENT, TRAINING, TALENT MANAGEMENT AND SUCCESSION PLANNING   54
25 AI, UNDER THE HOOD   51
24 RBMO VI   70
23 Recruitment, Training, Talent Management, and Succession Planning   109
22 PRISON AND ASSISTED REPRODUCTION   53
21 THE MINISTRY OF EMBRYOLOGY AND IMPLANTATION: DYNAMICS OF EMBRYO DEVELOPMENT I   50
20 Dynamic studies of embryo development in post-fertilization period - Implications for time lapse AI   50
19 The Role of the Y Chromosome in Infertility   56
18 THE ROLE OF THE Y CHROMOSOME IN INFERTILITY   56
17 Creating a Greener Clinic, The Triple Bottom Line   65
16 How Green is Your IVF?   74
15 Plastic Use in the IVF Lab   58
14 SUPPLY AND DEMAND: PERMANENT OF PER DIEM EMBRYOLOGISTS?   47
13 Minding the Gaps: Reflecting on the State of Embryologists   50
12 The nature of what we do or the excuse   106
11 THE INVISIBLE MALE   79
10 SESSION 107: HIGHLIGHTS OF THE 13TH BIENNIAL ALPHA CONGRESS   65
9 SESSION 108: EMBRIOLOGIA!   52
8 SESSION 110 : EXPLORING STRATEGIES TO IMPROVE FEMALE FERTILITY   54
7 SESSION 112 : THE INTELLIGENT SPERM   56
6 SESSION 113 : EMBRYOLOG   89
5 BEYOND THE WEBINAR - EMBRYO BIOPSY - LEVEL UP   86
4 Moving Sperm Forward   54
3 Laboratory Controlled Factors Impacting IVF Culture Media Performance   52
2 Evaluation of IVF laboratory outcomes with key performance indicators   52
1 Workflow efficiency related to iDAScore - Marcos Meseguer   77
 
Copyright IVFCPD Pty Ltd
Contact IVFCPD at Office@ivfcpd.com